Skip to main content
TipRanks
Go Ultimate75% OFF

ACADIA Pharmaceuticals (ACAD) Q2 2024 Earnings Report

2,464 Followers

ACAD Q2 2024 EPS Results

Actual EPS
$0.20
Consensus EPS
$0.18
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.01

ACAD Q2 2024 Revenue Results

Actual Revenue
$241.96M
Expected Revenue
$235.95M
Beat/Miss
Beat by +$6.02M
YoY Revenue Growth
+46.44%

Earnings Announcement Details

Quarter
Q2 2024
Date
08/06/2024
Time
After Close
Conference Call
Tuesday, August 6, 2024
ACAD Upcoming Earnings

ACADIA Pharmaceuticals's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

ACAD Q2 2024 Earnings Call
0:00 / 0:00

Q2 2024 Earnings Slide Deck

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

ACAD Earnings History

ACAD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 01, 20272026 (Q4)0.27-1.6――
Nov 04, 20262026 (Q3)0.200.310.42-26.19% (-0.11)
Aug 04, 20262026 (Q2)0.070.180.1612.50% (+0.02)
May 06, 20262026 (Q1)0.050.020.11-81.82% (-0.09)
Feb 25, 20262025 (Q4)0.141.600.8686.05% (+0.74)
Nov 05, 20252025 (Q3)0.170.420.2110.00% (+0.22)
Aug 06, 20252025 (Q2)0.140.160.2-20.00% (-0.04)
May 07, 20252025 (Q1)0.090.110.110.00% (+0.01)
Feb 26, 20252024 (Q4)0.220.860.28207.14% (+0.58)
Nov 06, 20242024 (Q3)0.140.20-0.4150.00% (+0.60)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed